ProfileGDS4132 / 203665_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 59% 54% 86% 75% 59% 61% 68% 71% 78% 75% 81% 90% 76% 69% 83% 83% 81% 76% 83% 78% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101165.94759
GSM201543Muscle PCOS pioglitazone 121140.26354
GSM201544Muscle PCOS pioglitazone 161370.77386
GSM201545Muscle PCOS pioglitazone 201255.80475
GSM201829Muscle PCOS pioglitazone 231172.36859
GSM201830Muscle PCOS pioglitazon 251176.65361
GSM201831Muscle PCOS pioglitazone 271203.99668
GSM201832Muscle PCOS pioglitazone 31204.9671
GSM201833Muscle PCOS pioglitazone 41248.73578
GSM201834Muscle PCOS pioglitazone 81240.12675
GSM201835Muscle PCOS after pioglitazone 102287.1981
GSM201836Muscle PCOS after pioglitazone 122442.82490
GSM201837Muscle PCOS after pioglitazone 162231.73276
GSM201838Muscle PCOS after pioglitazone 202202.09969
GSM201839Muscle PCOS after pioglitazone 232325.66983
GSM201840Muscle PCOS after pioglitazone 252327.26883
GSM201841Muscle PCOS after pioglitazone 272275.98881
GSM201842Muscle PCOS after pioglitazone 32216.80676
GSM201843Muscle PCOS after pioglitazone 42312.90683
GSM201844Muscle PCOS after pioglitazone 82269.5678